Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Ethan Knowlden, Terri Willey, Christoph Franz


Complete Genomics has appointed Ethan Knowlden to senior vice president, general counsel, and secretary. He joins the company from Novartis Vaccines and Diagnostics, where he was vice president of business development and licensing, and corporate counsel. He holds a JD from the University of Virginia, and a BA in art and economics from Wesleyan University.

Cold Spring Harbor Laboratories has appointed Teri Willey to vice president of business development and technology transfer, a newly created position. In this position, Willey will direct the lab's commercialization and technology transfer activities, including patenting, licensing, company start-ups, and corporate partnerships and collaborations. John Maroney, who was previously responsible for technology transfer activities, will continue in his role as general counsel.

Willey joins CSHL from Mount Sinai Medical Center, where she led the center's technology transfer and business development efforts as vice president of technology and business development. Previously, she was executive director of Cambridge Enterprise at the University of Cambridge and a co-founder and managing partner of ARCH Development Partners. She has also served as an advisor to Congress and a past President of the Association of University Technology Managers.

Roche has nominated Christoph Franz to chairman of the board of directors. He would succeed Franz Humer, who previously announced that he would not stand for re-election. Franz will not renew his contract as CEO of Lufthansa Group, which expires on May 31, 2014.